Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02800408 · ClinicalTrials.gov registry record · NA
Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02800408 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants.
The verdict
NCT02800408, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well the body absorbs the carotenoid beta-cryptoxanthin (BCX) from a type of corn that has been naturally bred (not genetically engineered) to contain higher amounts of BCX than traditional breeds of corn. Because this new type of corn contains higher amounts of BCX, it appears more orange in color than traditional types of corn. Understanding how well the body can absorb the BCX from the corn may help companies develop food products that may have improved nutritional quality.
Interventions
- OTHER Whole grain high-BCX maize
- OTHER Refined grain high-BCX maize
- OTHER Whole grain white maize
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-07-21 |
| Est. Completion | 2017-10-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02800408
The ClinicalTrials.gov registry entry for NCT02800408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Whole grain high-BCX maize is the first listed.
NCT02800408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02800408 about?
NCT02800408 is a clinical study titled "Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans". The purpose of this study is to determine how well the body absorbs the carotenoid beta-cryptoxanthin (BCX) from a type of corn that has been naturally bred (not genetically engineered) to contain higher amounts of BCX than traditional breeds of corn. Because this new type of corn contains higher am...
What is the current status of trial NCT02800408?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-07-21. Estimated completion is 2017-10-23.
What interventions are being tested in trial NCT02800408?
The interventions under investigation include: Whole grain high-BCX maize (OTHER), Refined grain high-BCX maize (OTHER), Whole grain white maize (OTHER).
Who is sponsoring clinical trial NCT02800408?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.